Trademark: 79202442
Word
NOSTER
Status
Dead
Status Code
709
Status Date
Friday, May 17, 2024
Serial Number
79202442
Registration Number
5319552
Registration Date
Tuesday, October 31, 2017
Mark Type
4
Filing Date
Tuesday, June 7, 2016
Published for Opposition
Tuesday, August 15, 2017
Cancellation Date
Friday, May 17, 2024

Trademark Owner History

Classifications
30 Tea; roasted, powdered or granulated coffee; coffee beverages; roasted, powdered or granulated cocoa; cocoa beverages; Japanese traditional confectionery; western-style confectionery; bread and buns; sandwiches; steamed buns stuffed with minced meat (Chuka-manjuh); hamburger sandwiches; pizzas; hot dog sandwiches; meat pies; cube sugar; fructose for culinary purposes; crystal sugar, not confectionery; sugar; maltose for culinary purposes; honey; glucose for culinary purposes; powdered starch syrup for culinary purposes; starch syrup for culinary purposes; ice cream mixes; sherbet mixes; flour
29 Milk products excluding ice cream, ice milk, and frozen yogurt; edible oils and fats; fresh, chilled or frozen meat for human consumption; fresh, chilled or frozen edible aquatic animals not live; processed meat products; processed seafood products other than blocks of boiled, smoked and then dried bonitos (Katsuo-bushi), dried pieces of agar jelly (Kanten), flakes of dried fish meat (Kezuri-bushi), fishmeal for human consumption, edible shavings of dried kelp (Tororo-kombu), sheets of dried laver (Hoshi-nori), dried brown alga (Hoshi-hijiki), dried edible seaweed (Hoshi-wakame) and toasted sheets of laver (Yaki-nori), namely, tinned seafood, processed fish; processed vegetables and fruits; protein for use as a food additive, namely, formed textured vegetable protein for use as a meat substitute and textured vegetable protein for use as a meat extender
5 Pharmaceutical preparations other than for agricultural purposes for the treatment and prevention of metabolic and endocrine diseases, namely, diabetes, diabetic complication, hyperlipidemia, hyperuricemia, gout, lifestyle related disease, nutritional disorders, impaired glucose tolerance, metabolic syndrome, obesity and lipid disorder, cardiovascular, urological and reproductive diseases, namely, hypertension, hyperglycemia, ischemic heart disease, hyperinsulinemia, arteriosclerosis, myocardial infarction, angina pectoris, aneurysm, chronic kidney disease, renal calculi, kidney disease, pyelonephritis, nephritis, urethritis, cystitis, hypercholesterolemia and high triglyceridemia, respiratory diseases, namely, bronchitis, pulmonary emphysema and lung inflammation, digestive and oral diseases, namely, abnormality of the intestinal flora, abdominal distension, peptic ulcer, intestinal disease, inflammatory disorder, irritable bowel syndrome, gastric ulcer, inflammatory bowel disease, Crohn's disease, diverticulitis, liver cirrhosis, fatty liver, diarrhea, constipation, loose stool disease, hepatic inflammation, non-alcoholic steatohepatitis, viral hepatitis, alcoholic hepatitis, dental disease, periodontal diseases, stomatitis, xerostomia and cyst, immune, inflammatory and allergic diseases, namely, immune related diseases and abnormalities, type I, II, III, IV and V allergy, pollinosis, atopic dermatitis, psoriasis, autoimmune disease and connective tissue disease, bone and articular diseases, namely, rheumatism, osteoporosis and articular inflammation, pathogenic microbial and malignant neoplastic diseases, namely, infection, cancer and malignant tumor, mental and nervous system diseases, namely, mental disorder, dementia, Alzheimer's disease, bipolar disorder, depression, anorexia, insomnia, cerebral apoplexy, cerebral infarction, autism, neuroinflammation, overwork related disease and nerve inflammation related diseases and cancers resulting from chronic inflammation, and sensory system and skin diseases, namely, ophthalmic disease, ocular inflammation, otorhinolaryngology disease and skin inflammation; pharmaceutical preparations in the nature of medicines for dental purposes; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wrapping wafers for medicine doses; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages; breast-nursing pads; cotton swabs for medical use; dental composite, impression and porcelain materials; dental materials, namely, dental porcelain materials, materials for making dental impressions and composite materials for dental and dental technical purposes; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals
3 Cosmetics; deodorant soaps and laundry detergents; dentifrices; perfume and flavour materials, namely, natural perfumery prepared from vegetables, natural perfumery prepared from animals, synthetic perfumery, blended perfumery and food flavorings prepared from essential oils; false nails; false eyelashes; breath freshening preparations; deodorants for animals; incenses and fragrances
1 Lactic acid bacteria powder for producing food, dietary supplements for humans or beverages; biological microorganisms for producing food, dietary supplements for humans or beverages; chemical additives for use in the manufacture of food, pharmaceuticals, cosmetics and animal feed; perfluorinated chemical compounds prepared synthetically for use in the manufacture of cosmetics and pharmaceuticals; food preserving chemicals; chemical preparations for preserving foodstuffs; chemical products for the fresh-keeping and preserving of food; chemical products for stabilizing foodstuffs; chemicals for industrial purposes; chemicals for use in the manufacture of a wide variety of goods; glue and adhesives for industrial purposes; plant growth regulating preparations; fertilizers; higher fatty acids for industrial purposes; unprocessed plastic; gluten for the food industry
32 Whey beverages; carbonated non-alcoholic drinks; fruit juices; vegetable juice; beer; extracts of hops for making beer
In the statement, page 2, line 15, "Hoshi-nori" should be deleted, and "(Hoshi-nori)" should be inserted in class 29.

Trademark Events
Mar 3, 2017
Non-Final Action Written
Mar 2, 2017
Sn Assigned For Sect 66a Appl From Ib
Mar 3, 2017
New Application Office Supplied Data Entered
Mar 3, 2017
Assigned To Examiner
Mar 4, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Mar 7, 2017
Application Filing Receipt Mailed
Mar 7, 2017
Refusal Processed By Mpu
Mar 7, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Mar 25, 2017
Refusal Processed By Ib
May 19, 2017
Teas Response To Office Action Received
May 19, 2017
Teas Change Of Correspondence Received
Jun 13, 2017
Assigned To Lie
Jun 22, 2017
Teas/Email Correspondence Entered
Jun 22, 2017
Correspondence Received In Law Office
Jul 8, 2017
Approved For Pub - Principal Register
Jul 26, 2017
Notification Of Notice Of Publication E-Mailed
Aug 2, 2017
Notification Of Possible Opposition Sent To Ib
Aug 2, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 15, 2017
Published For Opposition
Aug 15, 2017
Official Gazette Publication Confirmation E-Mailed
Aug 18, 2017
Notification Processed By Ib
Oct 31, 2017
Registered-Principal Register
Jan 10, 2018
Teas Section 7 Request Received
Jan 31, 2018
Final Disposition Notice Created, To Be Sent To Ib
Feb 6, 2018
Case Assigned To Post Registration Paralegal
Feb 6, 2018
Correction Under Section 7 - Processed
Feb 8, 2018
Final Disposition Notice Sent To Ib
Feb 8, 2018
Final Disposition Processed
Oct 31, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
May 17, 2024
Cancelled Section 71
Oct 23, 2020
Change Of Owner Received From Ib
Apr 13, 2018
Final Decision Transaction Processed By Ib

Trademark Alertz updated from USPTO on 2030-01-24